Joe Vogel serves as Senior Director, Program Leadership at Hemab, and is the Program Team Lead for HMB-001. In his 15 years in the biotech industry, he has held a variety of roles spanning clinical operations and program management. Joe’s focus has been in rare disease including lysosomal storage disorders, hemophilia, TTR amyloidosis and hereditary angioedema. He worked across a broad range of treatment modalities from small molecule, ERT, siRNA, and CRISPR, across all phases of development. Joe is a lifelong DE&I practitioner and volunteers on the Board of OUTbio, the biotech industry’s largest LGBTQ+ professionals group. Joe holds a Bachelor degree in Psychology from Syracuse University and a Master of Business Administration from University of Massachusetts Amherst.